IBDEI08A ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3747,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,3748,0)
 ;;=287.0^^33^283^52
 ;;^UTILITY(U,$J,358.3,3748,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3748,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,3748,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,3748,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,3749,0)
 ;;=782.1^^33^283^53
 ;;^UTILITY(U,$J,358.3,3749,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3749,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,3749,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,3749,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,3750,0)
 ;;=706.2^^33^283^56
 ;;^UTILITY(U,$J,358.3,3750,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3750,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,3750,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,3750,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,3751,0)
 ;;=690.10^^33^283^59
 ;;^UTILITY(U,$J,358.3,3751,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3751,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,3751,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,3751,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,3752,0)
 ;;=702.11^^33^283^57
 ;;^UTILITY(U,$J,358.3,3752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3752,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,3752,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,3752,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,3753,0)
 ;;=702.19^^33^283^58
 ;;^UTILITY(U,$J,358.3,3753,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3753,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,3753,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,3753,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,3754,0)
 ;;=686.9^^33^283^60
 ;;^UTILITY(U,$J,358.3,3754,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3754,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,3754,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,3754,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,3755,0)
 ;;=708.9^^33^283^70
 ;;^UTILITY(U,$J,358.3,3755,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3755,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,3755,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,3755,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,3756,0)
 ;;=078.10^^33^283^71
 ;;^UTILITY(U,$J,358.3,3756,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3756,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,3756,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,3756,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,3757,0)
 ;;=706.8^^33^283^72
 ;;^UTILITY(U,$J,358.3,3757,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3757,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,3757,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,3757,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,3758,0)
 ;;=710.1^^33^283^55
 ;;^UTILITY(U,$J,358.3,3758,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3758,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,3758,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,3758,2)
 ;;=Scleroderma^108590
 ;;^UTILITY(U,$J,358.3,3759,0)
 ;;=707.21^^33^283^43
 ;;^UTILITY(U,$J,358.3,3759,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3759,1,4,0)
 ;;=4^707.21
 ;;^UTILITY(U,$J,358.3,3759,1,5,0)
 ;;=5^Pressure Ulcer,Stage I
 ;;^UTILITY(U,$J,358.3,3759,2)
 ;;=^336649
 ;;^UTILITY(U,$J,358.3,3760,0)
 ;;=707.22^^33^283^44
 ;;^UTILITY(U,$J,358.3,3760,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3760,1,4,0)
 ;;=4^707.22
 ;;^UTILITY(U,$J,358.3,3760,1,5,0)
 ;;=5^Pressure Ulcer,Stage II
 ;;^UTILITY(U,$J,358.3,3760,2)
 ;;=^336650
 ;;^UTILITY(U,$J,358.3,3761,0)
 ;;=707.23^^33^283^45
 ;;^UTILITY(U,$J,358.3,3761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3761,1,4,0)
 ;;=4^707.23
 ;;^UTILITY(U,$J,358.3,3761,1,5,0)
 ;;=5^Pressure Ulcer,Stage III
 ;;^UTILITY(U,$J,358.3,3761,2)
 ;;=^336651
